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Abstract 19 
Objective: To assess the adequacy of reporting and conduct of narrative synthesis of quantitative 20 
data (NS) in reviews evaluating the effectiveness of public health interventions. 21 
Study design and setting: A retrospective comparison of a 20% (n=474/2372) random sample of 22 
public health systematic reviews from the McMaster Health Evidence database (January 2010-23 
October 2015) to establish the proportion of reviews using NS. From those reviews using NS, 30% 24 
(n=75/251) were randomly selected and data extracted for detailed assessment of: reporting NS 25 
methods; management and investigation of heterogeneity; transparency of data presentation; and 26 
assessment of robustness of the synthesis. 27 
Results: Most reviews used NS (56%, n=251/446), meta-analysis was the primary method of 28 
synthesis for 44%. In the detailed assessment of NS: 95% (n=71/75) did not describe NS methods; 29 
43% (n=32) did not provide transparent links between the synthesis data and the synthesis reported 30 
in the text; of 14 reviews that identified heterogeneity in direction of effect, only one investigated 31 
the heterogeneity; and 36% (n=27) did not reflect on limitations of the synthesis. 32 
Conclusion: NS methods are rarely reported in systematic reviews of public health interventions and 33 
many NS reviews lack transparency in how the data are presented and the conclusions are reached. 34 
This threatens the validity of much of the evidence synthesis used to support public health. 35 
Improved guidance on reporting and conduct of NS will contribute to improved utility of NS 36 
systematic reviews. 37 
 38 
Key words: systematic review, meta-research, methodology, narrative synthesis, evidence synthesis  39 
Running title: Reporting and conduct of narrative synthesis in systematic reviews 40 
Word count: 3055 41 
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What is new?  42 
Key findings 43 
• Based on a sample of public health reviews, it is apparent that, despite being commonly 44 
used, narrative synthesis often lacks transparency. 45 
• Synthesis methods are rarely reported, and presentation of data in the review often does 46 
not facilitate clear links between visual presentation of the data and the text.  47 
What this adds to what was known? 48 
• This is the first study to assess the adequacy of reporting of narrative synthesis of 49 
quantitative data in systematic reviews.  50 
What is the implication and what should change now? 51 
• Substantial improvements in clarity of reporting of narrative synthesis are required. There is 52 
a need for existing guidance to inform the development of a clear and concise reporting 53 
guideline for narrative synthesis. 54 
• Greater transparency when reporting narrative synthesis will allow end users including 55 
practitioners and policy decision-makers to have greater confidence in the results of 56 
systematic reviews that use narrative synthesis.  57 
  58 
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1 INTRODUCTION 59 
Well conducted systematic reviews have an important role in supporting evidence-informed policy 60 
and practice.[1, 2] The value of systematic reviews in supporting decision-making, compared with 61 
other types of review, is their use of a transparent method to draw conclusions based on the best 62 
available evidence. While meta-analysis is a cornerstone of many systematic reviews, statistical 63 
pooling may not always be appropriate or feasible due to high levels of heterogeneity or lack of 64 
available data to calculate standardised effect estimates (e.g. standardised mean difference, odds 65 
ratio, risk ratio). Heterogeneity, both statistical and methodological, is a common issue for public 66 
health reviews where it is typical to include diverse study designs, outcomes, contexts, populations, 67 
and interventions.[3] When meta-analysis is inappropriate or not possible, data may be synthesised 68 
narratively; this method is relied on heavily by those conducting reviews addressing public health 69 
issues. For example, 74% of National Institute for Health and Care Excellence (NICE) public health 70 
appraisals included NS.[4]  71 
Concerns have been raised that Narrative Synthesis of quantitative data (NS) lacks transparency and 72 
has substantial potential for bias.[5-7] Specifically, there is concern that conclusions of NS are based 73 
on subjective interpretation[5, 7] with a risk of over emphasising selected results without clear 74 
justification. This lack of transparency, limits assessment of the level and sources of bias in NS,[5] 75 
threatens the replicability of the method, and may ultimately threaten the validity and value of 76 
review findings based on NS. However, empirical evaluations of the reporting and adequacy of NS 77 
are lacking. This paper presents the findings of a systematic review that aimed to establish current 78 
practice, and adequacy of reporting and conduct of NS of quantitative data in public health 79 
systematic reviews. 80 
2 METHODS  81 
To assess reporting and conduct of NS, we identified a random sample of recent public health 82 
systematic reviews and systematically assessed the adequacy of reporting and conduct by 83 
benchmarking against available published guidance. The methods of this review are described 84 
below, further details are available in the review protocol.[8] 85 
To establish existing guidance on NS, we consulted publications, textbooks and methods papers, 86 
these are outlined in Box 1, along with the key elements of NS from the most comprehensive 87 
guidance of provided by Popay et al.[9] For the purposes of this work, we used the definition of NS 88 
as proposed by Popay et al. in the UK’s Economic and Social Research Council (ESRC) guidance:  89 
“Narrative synthesis refers to an approach to the systematic review and synthesis of findings from 90 
multiple studies that relies primarily on the use of words and text to summarise and explain the 91 
findings of the synthesis. Whilst narrative synthesis can involve the manipulation of statistical data, 92 
the defining characteristic is that it adopts a textual approach to the process of synthesis to ‘tell the 93 
story’ of the findings from the included studies”.[9, page 5]  94 
Box 1: Overview of ESRC guidance on narrative synthesis[9] and additional key sources consulted 95 
to establish best practice in narrative synthesis 96 
The most comprehensive guidance on the conduct and reporting of NS was published in 2006,[9] 
commonly known as the ‘ESRC guidance on NS’. The general elements of narrative synthesis set 
out by Popay et al.[9] (page 12-16): 
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1. Developing a theoretical model of how the interventions work, why and for whom 
 
2. Developing a preliminary synthesis: develop an initial description of the results of 
included studies. 
Tools and techniques suggested: textual descriptions of studies, groupings and clusters, 
tabulation, transforming data into a common rubric, vote counting, translating data 
thematic analysis, content analysis. 
 
3. Exploring relationships in the data: examine emerging patterns in data to identify any 
explanations for differences in direction or size of effect across included studies 
Tools and techniques suggested: graphs, frequency distributions, funnel plots, forest 
plots, moderator variables and sub group analysis, idea webbing and conceptual mapping, 
translation reciprocal and refutational, qualitative case descriptions, 
investigator/methodological triangulation, conceptual triangulation 
 
4. Assessing the robustness of the synthesis product: trustworthiness of the synthesis, 
incorporating the methodological quality of the included studies and the methods used in 
the synthesis. 
Tools and techniques suggested: weight of evidence, best evidence synthesis, use of 
validity assessment, reflecting critically on the synthesis process, checking the synthesis 
with authors of primary studies. 
 
Additional sources consulted to develop data extraction tool:  
 
• An introduction to systematic reviews [11] 
• Systematic reviews in the social sciences: a practical guide [12] 
• Synthesising qualitative and quantitative health evidence: a guide to methods [13] 
• Guidelines for systematic reviews of health promotion and public health interventions 
[14] 
• Cochrane handbook for systematic reviews of interventions [5] 
• WHO Handbook for guideline development [16] 
 97 
 98 
2.1 Search strategy, inclusion criteria and review selection 99 
We obtained a download of systematic reviews, from the McMaster Health Evidence database 100 
(http://www.healthevidence.org/), which were published between January 2010 and October 2015 101 
inclusive. The Health Evidence database contains systematic reviews relevant to public health which 102 
meet each of the following criteria: address questions related to promotion, protection or 103 
prevention in public health or health; include participants from developed countries; examine an 104 
intervention/programme/service/policy; include evidence on outcomes; and describe a search 105 
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strategy (see http://www.healthevidence.org/our-appraisal-tools.aspx). The Health Evidence 106 
database uses a validated search filter which has high sensitivity, specificity and precision for 107 
retrieving systematic reviews of public health interventions.[10] In addition to the database inclusion 108 
criteria, we specified that reviews had to be systematic and contain synthesis; we excluded expert 109 
reviews, overviews, empty reviews and reviews with no synthesis. 110 
Using the Microsoft Excel
©
 random number function, a 20% random sample was selected from the 111 
full Health-Evidence database download. The Excel random number function was used to allocate a 112 
number to each database entry (the results of the Health Evidence database search) and numbers 113 
were sorted lowest to highest. The first 20% of the random numbers were used to identify and 114 
include the corresponding Health Evidence reviews. This sample of reviews was screened (by MC, 115 
HT, AS, SVK) to identify reviews using NS of quantitative data for their primary outcome. If the 116 
review did not state a primary outcome, we identified the “primary outcome” of interest by the 117 
review question(s). A further 30% sub-sample of reviews which used NS as the primary method of 118 
synthesis was randomly selected for more detailed data extraction and analysis.  119 
2.2 Data extraction  120 
The data extraction form was designed to reflect key elements of good practice in the conduct and 121 
reporting of NS of quantitative data. Key sources on the conduct of NS of quantitative data[11-16] 122 
informed the design of the data extraction form. (See Box 1) Three members of the research team 123 
(MC, HT & SVK) read the key sources independently and prepared a list of items or components that 124 
were common in the key sources. The lists were then collated to prepare items for inclusion in the 125 
draft data extraction form, which was then finalised in discussion with all authors (online Supporting 126 
Information file, Appendix Table S1). There was little variation in recommended practice for NS 127 
across the identified sources. The ESRC guidance provided the most comprehensive explanation and 128 
the other sources appeared to draw heavily on this guidance.[9] The data extraction form, therefore, 129 
largely reflects the core components recommended in the ESRC guidance. Five main aspects of NS 130 
were identified and covered by the data extraction exercise, namely:  131 
• Reporting of NS methods  132 
• Use of theory (i.e. articulation of how the intervention is expected to work) 133 
• Management and investigation of heterogeneity across studies 134 
• Transparency of data presentation and links to narrative 135 
• Assessment of robustness of the synthesis (i.e. reflection of the synthesis methods used to 136 
assess the strength of the evidence from the included studies) 137 
Two reviewers (MC and HT) independently piloted the data extraction form. All members of the 138 
project team conducted data extraction on a selection of the same five reviews until assessments 139 
were consistent across each member of the research team (MC, HT, SVK, AS). The data were entered 140 
directly into a Microsoft Excel© database. Health Evidence quality assessment ratings of the reviews 141 
were gathered after the data extraction exercise was complete. 142 
2.3 Summarising the data 143 
The extracted data were tabulated to reflect the five main aspects of NS (see above) and are 144 
described narratively, with frequencies and descriptive data. Text was extracted to illustrate the 145 
reporting of NS methods.  146 
3 Results 147 
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A total of 2372 systematic reviews of public health interventions published between January 2010 148 
and October 2015 were available from The McMaster Health Evidence database (see Figure 1). From 149 
the initial 20% (n=474/2372) random sample of reviews, 28 (6%) were excluded as they did not fit 150 
our inclusion criteria: not systematic review (expert review/overview) (n=8) or were empty reviews 151 
(contained no studies) (n=2). We were unable to retrieve the full text of 18 further reviews. Of the 152 
446 reviews included, 251 (56%) synthesised the data for the primary outcome narratively; of these, 153 
215 (48%) used NS exclusively, and 36 (8%) used a combination of NS and meta-analysis for primary 154 
outcome data (i.e. some data were included in the meta-analysis, with other data reported and 155 
discussed in the narrative text). The remaining reviews (44%, n=195) used meta-analysis to 156 
synthesise the primary outcome data.  157 
3.1 Included reviews 158 
All of the included reviews were published in international peer review journals. For a list of the 159 
included reviews, see Appendix Table S2. A list of results of extracted items reported in the text of 160 
this paper is provided in Appendix Table S3. The McMaster Health Evidence database provides a 161 
quality assessment of each included review, this is based on a ten-item quality assessment tool that 162 
covers all aspects of the systematic review process. The assessment incorporates clarity of review 163 
question, appropriate search strategy, and risk of bias assessment, and two items assessing aspects 164 
of synthesis (‘Was it appropriate to combine the findings of results across studies?’, ‘Were 165 
appropriate methods used for combining or comparing results across studies?’) 166 
(https://www.healthevidence.org/our-appraisal-tools.aspx.). We randomly selected and analysed 167 
the 75 reviews in our sample blind to the Health Evidence quality assessment scores and retrieved 168 
these scores after our data extraction exercise was complete. Of the reviews in our sample, 37% had 169 
a strong rating (score of 8 to 10/10), 60% moderate (score of 5 to 7/10), and 3% weak (score of 1 to 170 
4/10). Therefore, we are confident that the majority of the sample reviews followed good practice; 171 
however that assessment process did not fully examine the synthesis processes in the systematic 172 
reviews. 173 
The following sections report on the detailed data extraction conducted on the 30% (n=75/251) 174 
random sample of the reviews that synthesised data narratively. 175 
3.2 Reporting of narrative synthesis methods  176 
While 75 reviews synthesised data narratively, i.e. using text only, a description of the methods used 177 
for NS was absent in 95% of the reviews (n=71). Where methods were reported, the description was 178 
typically sparse, see examples in Box 2. Few review authors used the term ‘narrative synthesis’ to 179 
describe their synthesis; 27% (n=20/75) described their synthesis as ‘narrative’ or ‘qualitative’, and 180 
justification for using NS was rarely provided (15%, n=3/20). In around half (51%, n=38/75) of the 181 
reviews using NS, the authors stated that they were unable to conduct a meta-analysis but provided 182 
no further details of how the data were synthesised (Table 1, items 1.1 – 1.3).  183 
Box 2: Examples of narrative synthesis description 184 
 185 
Examples of narrative synthesis description 
“A narrative synthesis was undertaken for each category of intervention to compare the effects 
of each on cervical screening uptake” Albrow R, Blomberg K, Kitchener H, et al. Acta Oncologica 
2014; 53:445-51. 
"The heterogeneous nature of the literature meant that a largely narrative synthesis approach 
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was employed [citation provided].” Abendstern M, Harrington V, Brand C, Tucker S, Wilberforce 
M, Challis D. Aging Ment Health 2012; 16:861-73.  
“Because of heterogeneity in outcomes and outcome assessment methodology, meta-analysis 
was not undertaken. Results are presented in narrative form.” Golley RK, Hendrie GA, Slater A, 
Corsini N. Obesity Rev 2011; 12:114-30. 
“Results are presented as a narrative synthesis. Equity effect was summarised [citation 
provided].” Gallo MF, Nanda K, Grimes DA, Lopez LM, Schulz KF. Cochrane Database Syst Rev 
2013; 2013:Art. No.: CD003989. 
“Due to variability in participant and intervention characteristics, assessment tools used to 
diagnose frailty, and outcome measures used across studies, a meta-analysis could not be 
satisfactorily performed. Meta-analysis should only be considered when a group of studies have 
sufficient homogeneity between participants, interventions, and outcomes to provide a 
meaningful summary. In accordance with the Cochrane library if there is substantial clinical 
diversity a qualitative approach combining studies is appropriate.” Theou O, Stathokostas L, 
Roland KP, et al. J Aging Res 2011;2011: Art. no: 569194. 
For mixed meta-analysis and narrative synthesis: "Two studies that were conducted in children 
were not included in the meta-analyses and are reported separately." Balk EM, Earley A, Raman 
G, Avendano EA, Pittas AG, Remmington PL. Ann Intern Med 2015: 437-51.  
 186 
Table 1 Reporting and conduct of narrative synthesis  187 
 188 
 Reviews which synthesised data narratively 
(n=75) 
1 Reporting narrative synthesis (NS) methods and use of theory 
1.1 Method of narrative synthesis described 
 
Yes                                                      5%  (n=4)  
State did NS, no description      16%  (n=12)  
No mention of NS                        79%  (n=59) 
1.2 Do authors state they will conduct 
narrative synthesis? 
Yes                                                  27%  (n=20) 
No                                                   73%  (n=55) 
1.3 What justification is given for using 
narrative synthesis? 
Cannot conduct meta-analysis  51%  (n=38) 
NS most appropriate method       4%   (n=3) 
Providing summary of data           3%   (n=2)  
No justification provided               5%   (n=4)  
N/A (did not say would do NS)  37%  (n=28)  
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1.4 Theory/rationale for how the 
intervention(s) of interest is expected to work 
(prior to synthesis) 
Explicit                                           47%  (n=35)  
Implicit                                          43%  (n=32)   
None                                               10%   (n=8) 
2 Management and investigation of heterogeneity across studies  
2.1 Were data/studies split into sub-groups 
for presentation of synthesis? 
Yes                                                 80%  (n=60) 
No                                                 20%   (n=15) 
 2.2 If data/studies not split into sub-groups, 
was there justification for this? 
Yes                                                       0%    (n=0) 
No                                                     20%   (n=15) 
N/A (data split into sub-groups)  80%  (n=60) 
2.3 If studies were grouped/split, how were 
the studies grouped?  
 
(multiple groupings in some reviews) 
Study design                                          (n=13) 
Risk of bias                                               (n=5) 
Intervention                                           (n=36) 
Population                                                (n=9) 
Context (country, location/setting)    (n=6) 
Outcome                                                (n=26) 
Other                                                         (n=6) 
(Other = whether replication studies available 
(1), mechanisms (1), theoretical basis (3), 
comparisons(1)) 
2. 4Did review authors identify heterogeneity 
in the direction of the primary outcome?  
 
Yes                                                 19%  (n=14) 
No                                                  60%  (n=46) 
Unclear                                         21%  (n=15) 
2.5 If the authors reported heterogeneity in 
direction of primary outcome, was there any 
attempt to explain this? 
To a large extent                             2%   (n=1) 
To some extent                            13%  (n=10)  
No                                                      9%   (n=7) 
N/A                                                 75% (n=56) 
(on some occasions we commented on an 
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‘unclear whether heterogeneity identified’ item ) 
3 Transparency of data presentation and links to narrative 
3.1 Did presentation of data facilitate clear 
links between the text and the data for the 
reader? 
 
Yes                                                 57%  (n=43)  
Partially                                        32%  (n=24)  
No                                                     5%   (n=4) 
No data presented in a table       5%   (n=4) 
3.2 The summary of characteristics table(s) 
provide details of: 
 
Study design                               95%  (n=71) 
Risk of bias                                  52%  (n=39) 
Intervention                                 95%  (n=71) 
Population                                   88%  (n=66) 
Outcome                                      88%  (n=66) 
Context (country, location/setting) 
                                                      65%  (n=49) 
Other                                           47%  (n=35) 
(Other includes: sampling strategy, theory, 
follow up time, details of study control groups, 
brief results) 
3.3 In the conclusion, are the key findings 
clearly referring back to evidence in results 
(text or table/figure)? 
Yes                                                 60%  (n=45) 
To some extent                            33%  (n=25) 
Unclear                                             7%   (n=5) 
4 Robustness of synthesis  
4.1 Authors’ reflections on limitations of 
synthesis 
Free text, broadly coded: 
Inclusion criteria                          35%  (n=26) 
Heterogeneity                              21%  (n=16) 
  (study characteristics, outcomes and analysis)   
Generalisability of review findings 
                                                          4%  (n=3) 
Analysis                                         11%  (n=8) 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
11 
 
  (alternative analysis/coding possible 
  lack of meta-analysis) 
No mention of limitations of synthesis 
                                                    36%  (n=27) 
4.2 Authors’ reflections on limitations of 
evidence 
Free text, broadly coded: 
Inadequate study quality             32%  (n=24) 
Lack of high quality evidence      13%  (n=10) 
Relevant/available studies           19%  (n=14) 
Lack of intervention details         19%  (n=14) 
Heterogeneity of measurement outcomes 
                                                            5%   (n=4) 
No mention of limitations of evidence  
                                                          12%  (n=9) 
 189 
Ten reviews (13%) reported the type of synthesis approach that was followed or referred to specific 190 
guidance or methods texts: ESRC guidance (n=2);[9] NICE guidelines (n=1);[15] the Cochrane 191 
handbook (n=2);[5] thematic synthesis (n=1);[17] integrative review (n=1);[18] ‘formative’ review 192 
(n=1); ‘freeplane’ (n=1); and vote counting (n=1).  193 
3.3 Use of theory 194 
Nearly all (90%, n=67) of reviews reported how the intervention was expected to work or impact on 195 
the primary outcome. Around half of the reviews (47%, n=35) did this explicitly, with two including a 196 
visual diagram to illustrate the mechanisms of action. A further 10% (n=8) did not report any theory 197 
of change. (Table 1, item 1.4) 198 
3.4 Management and investigation of heterogeneity across studies 199 
Diversity of study characteristics was dealt with in most (80%, n=60) reviews by creating categories, 200 
usually by intervention, outcomes, or study design before conducting and presenting the synthesis 201 
(Table 1, item 2.1, 2.3). Two reviews (3%) reported conducting preliminary synthesis, a component 202 
of NS recommended in the ESRC guidance on NS.[9] 203 
A small number of reviews (19%, n=14) reported heterogeneity in the direction of effect in the 204 
reported outcomes, (positive, negative or null effect, for the primary outcome) (Table 1, item 2.4). 205 
The lack of protocols for most reviews prevented recording whether investigation of heterogeneity 206 
was pre-specified. This study was not assessing the appropriateness of the investigation of 207 
heterogeneity. This would require expertise in the topic of investigation for all the reviews, which 208 
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our project team did not have. Rather, we describe how investigation of heterogeneity was 209 
conducted. Only one review investigated heterogeneity in the direction of effect; specifically, the 210 
authors explored differences in intervention components (treatment regimens) across studies, and 211 
provided an explanation for the heterogeneity. Ten reviews provided hypothetical explanations for 212 
the variance in reported effect directions and three reviews did not offer any explanation. 213 
Hypothesised explanations for heterogeneity focussed on differences in the characteristics or 214 
outcome measures of interventions, or the risk of bias of included studies. In one review (2%) the 215 
authors linked their hypothesised explanation of heterogeneity in reported effects to a pre-specified 216 
theory, suggesting that intervention adherence influenced the outcome. 217 
3.5 Transparency of data presentation and links to narrative 218 
Tables presenting outcome data were provided in 85% (n=64) of reviews, either alongside the text or 219 
as an online appendix. While 54% (n=40) of the reviews made the full data extraction available, 220 
either in the article (43%, n=32) or online (11%, n=8), the remaining 47% (n=35) of reviews did not 221 
provide access to all the data incorporated into the synthesis. In 15% (n=11) of reviews, not all the 222 
included studies were referred to in the narrative, leading to uncertainty as to whether the data 223 
from these studies had been included.  224 
Using information about the type, detail, and clarity (including grouping) of reporting of data in each 225 
review, we assessed transparency; 57% (n=43) of reviews were assessed as promoting transparent 226 
links between the data and the text. A summary table presenting key characteristics of included 227 
studies was included in 97% (n=73) of reviews; providing information about study design, 228 
intervention, population, and outcomes (Table 1, item 3.1, 3.2).  229 
We also assessed the extent to which review conclusions were linked to the included data, based on 230 
how clearly the conclusions referred to the reported results. We judged this to be clear, (i.e. the key 231 
findings in the conclusion clearly referred back to the text or visual evidence in the results), to a large 232 
extent or to some extent for most reviews (n=45 and n=25 respectively); however, in 7% (n=5) of 233 
reviews there was no clear link between the conclusions and the evidence referred to in the 234 
synthesis. 235 
3.6 Assessment of the robustness of the synthesis 236 
When considering the strengths and limitations of the evidence, review authors were more likely to 237 
reflect on the limitations of the primary studies included in the review (88%, n=66), rather than 238 
limitations of the synthesis they had conducted (64%, n=48). Limitations referred to risk of bias in 239 
included studies, relevance and reporting of study and intervention details, and heterogeneity of 240 
outcome measurements (Table 1, item 4.1). Where limitations of the synthesis were reported these 241 
included search and inclusion criteria (e.g. search limited to published articles, only English language 242 
text included), heterogeneity of study characteristics, outcomes, and generalisability of the review 243 
findings to other settings or populations (Table 1 item 4.2).  244 
Each assessor provided an overall subjective assessment of the level of trust in the results of each 245 
synthesis; 44% (n=33) were considered to be trusted ‘to a large extent’, 44% (n=33) ‘to some extent’ 246 
and ‘did not trust the synthesis’ in 12% (n=9) of reviews assessed. See Appendix Table S4 for 247 
comparison of the project team’s level of trust of review syntheses with the Health Evidence quality 248 
rating.  249 
4 Discussion 250 
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Narrative synthesis is more commonly used than meta-analysis for synthesising quantitative data in 251 
systematic reviews of public health interventions. Despite its popularity, our detailed assessment 252 
shows that reporting of NS methods is almost totally absent, and the transparency of how NS is 253 
conducted is variable and currently inadequate. In 95% of reviews relying on NS for their primary 254 
outcome, all from international peer review journals, the methods used were not described. While 255 
the majority of reviews did incorporate some core components of good practice (describing the 256 
rationale for the intervention, transparently relating tabulated data to the text in the results, and 257 
reflecting on the robustness of the synthesis), fewer than 30% of the reviews adopted each of these 258 
components. Our findings support previous criticism of NS as being opaque, particularly in relation 259 
to interpreting the evidence and being susceptible to selective reporting. This potential for bias is 260 
important and threatens the value of systematic reviews that use NS. In public health, where NS is 261 
commonly used, these are important issues undermining the role of these key resources as tools to 262 
support evidence informed decision making in public health. 263 
The findings of our work are based on a representative sample of reviews from the Health Evidence 264 
database; a comprehensive source of systematic reviews of public health interventions.[10] 265 
Limitations of our study include the lack of a gold standard with which to compare reporting of NS. 266 
We used single assessors for data extraction, however this was only after good agreement in the 267 
data extraction was achieved between independent assessors. Our sample of reviews allows an 268 
overall assessment of current practice within public health reviews, but we are aware that the 269 
sample is too small to allow robust comparison of reporting and conduct in reviews from different 270 
disciplines or different health topics. Despite the focus on public health, the findings are likely to be 271 
relevant to the wider field of evidence synthesis, regardless of topic. Indeed, we suspect that the 272 
conduct of NS may be poorer in other topic areas where there is less familiarity with NS as a method. 273 
NS will continue to be a necessary method of synthesis due to the complex nature of many 274 
interventions and the need to support evidence informed decision making.[19] 275 
The limited reference to available guidance on NS and the near absence of reporting of NS methods, 276 
suggests that there is a general lack of familiarity with NS as a method among review authors. 277 
Furthermore, the lack of justification for using NS beyond statements such as ‘it was not possible to 278 
conduct meta-analysis’ suggests that review authors may not consider NS to be a discrete method of 279 
synthesis. This is supported by our own informal discussions with experienced review authors who 280 
have expressed uneasiness around how to conduct and assess NS, yet acknowledge that NS is an 281 
important and essential method for reviews with high levels of heterogeneity and where diverse 282 
types of evidence are included. 283 
Despite its frequent use, development of NS methods has been scant. This is in contrast to work to 284 
promote rigor in statistical synthesis or meta-analysis,(5) as well as more recent work to improve 285 
synthesis of qualitative data.[17, 20, 21] Similarly, reporting guidelines for meta-analysis 286 
(PRISMA),[22] meta-ethnography (EMERGE)[23] and synthesis of qualitative data (ENTREQ)(24) are 287 
widely available, yet relatively little has been written on how to promote transparency in the 288 
conduct and reporting of NS. This further supports the notion that NS of quantitative data is not 289 
widely recognised as a discrete synthesis method. 290 
Increasingly, systematic reviews need to address questions about complex interventions and go 291 
beyond straightforward questions of effectiveness.[3, 4, 19, 25-28] This issue goes beyond public 292 
health; the Cochrane 2020 strategy points to a move towards incorporating more diverse sources of 293 
evidence and addressing complex health decision making questions.[29] NS is well placed to support 294 
these types of reviews, not only as an alternative when meta-analysis is contra-indicated but as an 295 
important synthesis tool in its own right. It offers a method for exploring and understanding the 296 
M
A
N
U
S
C
R
IP
T
 
A
C
C
E
P
T
E
D
ACCEPTED MANUSCRIPT
14 
 
underlying arguments and justification of claims made in the included studies of a review.(28) NS 297 
enables reviewers to incorporate diversity in study designs, participants, interventions or outcomes.  298 
NS is likely to remain an important method for bringing together heterogeneous evidence. The work 299 
reported here shows that current practice in the conduct and in particular, the reporting of NS, is not 300 
consistent with the standards of transparency expected from rigorous and reliable systematic 301 
reviews. There is a need to provide support to those conducting NS and those attempting to assess 302 
the reliability of NS of quantitative data. NS is used in Cochrane reviews, perhaps more often than 303 
presumed. We estimated at least 20% of recent Cochrane reviews used NS to synthesise outcome 304 
data.[30] We intend to contribute to the improved use of NS with The Improving the Conduct and 305 
reporting Of Narrative Synthesis of Quantitative data (ICONS-Quant) project, supported by the 306 
Cochrane Strategic Methods Fund which aims to produce guidance and reporting guidelines for 307 
authors conducting NS of quantitative data (http://www.equator-network.org/library/reporting-308 
guidelines-under-development/#74). Improved guidance has been linked to improved reporting of 309 
research,[31] without which it is difficult for decision-makers to make use of research findings in the 310 
real world.[32] 311 
 312 
5 Conclusion 313 
Narrative Synthesis is a valuable method for synthesising quantitative data where meta-analysis is 314 
not appropriate. While NS of quantitative data is widely used, it is poorly reported and transparency 315 
is often lacking, threatening the credibility and value of many systematic reviews.  The poor 316 
reporting suggests a lack of familiarity with, and confidence about, how to implement best practice 317 
when conducting NS. Improved guidance on the conduct and reporting of NS of quantitative data is 318 
required to support authors and ensure reviews using NS can be reliably used by decision makers. 319 
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Figure 1 Review selection flow chart 
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Transparency in the reporting and conduct of narrative synthesis of quantitative data: a cross-
sectional comparison of systematic reviews  
What is new?  
Key findings 
• Based on a sample of public health reviews, it is apparent that, despite being commonly 
used, narrative synthesis often lacks transparency. 
• Synthesis methods are rarely reported, and presentation of data in the review often does 
not facilitate clear links between visual presentation of the data and the text.  
What this adds to what was known? 
• This is the first study to assess the adequacy of reporting of narrative synthesis of 
quantitative data in systematic reviews.  
What is the implication and what should change now? 
• Substantial improvements in clarity of reporting of narrative synthesis are required. There is 
a need for existing guidance to inform the development of a clear and concise reporting 
guideline for narrative synthesis. 
• Greater transparency when reporting narrative synthesis will allow end users including 
practitioners and policy decision-makers to have greater confidence in the results of 
systematic reviews that use narrative synthesis.  
 
